Seladelpar for primary biliary cholangitis

被引：0
|
作者：
Baker, Holly
机构：
来源：
LANCET GASTROENTEROLOGY & HEPATOLOGY | 2024年 / 9卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：414 / 414
页数：1
相关论文
共 50 条
  • [21] Primary Biliary Cholangitis and Primary Sclerosing Cholangitis
    Yokoda, Raquel T.
    Carey, Elizabeth J.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 (10): : 1593 - 1605
  • [22] Seladelpar improved measures of pruritus, sleep, and fatigue and decreased serum bile acids in patients with primary biliary cholangitis
    Kremer, Andreas E.
    Mayo, Marlyn J.
    Hirschfield, Gideon
    Levy, Cynthia
    Bowlus, Christopher L.
    Jones, David E.
    Steinberg, Alexandra
    McWherter, Charles A.
    Choi, Yun-Jung
    LIVER INTERNATIONAL, 2022, 42 (01) : 112 - 123
  • [23] Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis
    Sarcognato, Samantha
    Sacchi, Diana
    Grillo, Federica
    Cazzagon, Nora
    Fabris, Luca
    Cadamuro, Massimiliano
    Cataldo, Ivana
    Covelli, Claudia
    Mangia, Alessandra
    Guido, Maria
    PATHOLOGICA, 2021, 113 (03) : 170 - 184
  • [24] Primary Biliary Cholangitis
    Andrew R. Scheinberg
    Cynthia Levy
    Current Treatment Options in Gastroenterology, 2022, 20 (3) : 469 - 483
  • [25] Primary Biliary Cholangitis
    Suraweera, Duminda
    Reynolds, Courtney
    Thangaratnam, Shehan
    Singhvi, Gaurav
    PRACTICAL GASTROENTEROLOGY, 2016, 40 (01) : 48 - 59
  • [26] PRIMARY BILIARY CHOLANGITIS
    Iljinsky, I. M.
    Tsirulnikova, O. M.
    VESTNIK TRANSPLANTOLOGII I ISKUSSTVENNYH ORGANOV, 2021, 23 (01): : 162 - 170
  • [27] Primary biliary cholangitis
    Lleo, Ana
    Wang, Giu-Qiang
    Gershwin, Merrill Eric
    Hirschfield, Gideon M.
    LANCET, 2020, 396 (10266): : 1915 - 1926
  • [28] Primary biliary cholangitis
    Tanakai, Atsushi
    Mai, Xiong
    Takahashi, Atsushi
    Vierling, John M.
    LANCET, 2024, 404 (10457): : 1053 - 1066
  • [29] Primary biliary cholangitis
    Brierley, Rob
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2018, 3 (06): : 379 - 379
  • [30] A phase II, randomized, open-label, 52-week study of seladelpar in patients with primary biliary cholangitis
    Bowlus, Christopher L.
    Galambos, Michael R.
    Aspinall, Richard J.
    Hirschfield, Gideon M.
    Jones, David E. J.
    Doerffel, Yvonne
    Gordon, Stuart C.
    Harrison, Stephen A.
    Kremer, Andreas E.
    Mayo, Marlyn J.
    Thuluvath, Paul J.
    Levy, Cynthia
    Swain, Mark G.
    Neff, Guy W.
    Sheridan, David A.
    Stanca, Carmen M.
    Berg, Christoph P.
    Goel, Aparna
    Shiffman, Mitchell L.
    Vierling, John M.
    Boudes, Pol
    Steinberg, Alexandra
    Choi, Yun-Jung
    McWherter, Charles A.
    JOURNAL OF HEPATOLOGY, 2022, 77 (02) : 353 - 364
12345